Mannatech (MTEX) Amends Form 4 — 20,000 Options, Change-in-Control Acceleration
Rhea-AI Filing Summary
Mannatech Inc. (MTEX) reporting person Fredrick Landen Granvel, President and CEO, amended a Form 4 to correct the vesting schedule for a stock option grant dated 06/03/2025. The amendment states the options (20,000 shares underlying) have a three-year vesting schedule: one-third on each anniversary of the grant, with immediate vesting upon a change in control. The options have a $10.60 exercise price and expire 06/03/2035. The report also shows a sale of 3,975 shares of common stock and a total beneficial ownership of 44,000 shares following the transactions. The amendment corrects an earlier filing that contained an incorrect vesting schedule.
Positive
- Clarified vesting schedule improves transparency by specifying one-third vesting each anniversary over three years.
- Change-in-control acceleration provides clear terms that protect executive interests and are disclosed to investors.
- Option grant details are explicit: 20,000 options at a $10.60 exercise price expiring 06/03/2035.
Negative
- Insider sale of 3,975 shares reduces the reporting person's direct holdings.
- Original Form 4 contained incorrect vesting information, requiring an amendment which may raise minor disclosure control questions.
Insights
TL;DR: CEO amended Form 4 fixing option vesting; 20,000 options granted at $10.60 with standard three-year vesting and change-in-control acceleration.
The amendment clarifies the vesting cadence for a material option grant rather than altering economics: 20,000 options exercisable through 2035 at $10.60 and vesting in three equal annual tranches. Such a schedule aligns management incentives with multi-year performance while the change-in-control acceleration provides common protection for executives. A contemporaneous sale of 3,975 shares reduces direct holdings but does not materially change total reported beneficial ownership of 44,000 shares.
TL;DR: Amendment corrects disclosure; vesting terms and change-in-control clause are explicit, improving transparency for investors.
Filing an amendment to correct vesting details improves disclosure quality and reduces ambiguity about executive compensation timing. The three-year cliff/annual tranche approach and explicit acceleration on change in control are common governance features. The record shows standard Section 16 reporting practices with a POA signature, and the corrected schedule helps investors assess potential dilution timing from option exercises.